Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Older NHL survivors show worse cognitive decline

Key clinical point: Older long-term survivors of non-Hodgkin lymphoma (NHL) may have worse cognitive outcomes compared with the noncancer aging population.

Major finding: NHL survivors had a higher mean number of chronic conditions (3.4 vs. 2.3, P = .003), were receiving more medications (3.4 vs. 2.3, P = .003), and had worse functional status compared with controls.

Study details: A cross-sectional comparative study involving 63 long-term survivors of NHL and 61 age-matched controls.

Disclosures: No funding sources were reported. The authors reported having no conflicts of interest.


La Carpia D et al. J Geriatr Oncol. 2020 Jan 31. doi: 10.1016/j.jgo.2020.01.007.